National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

RPI.4610

 A substance that is being studied in the treatment of kidney cancer. It may prevent the growth of blood vessels from surrounding tissue to the tumor. It belongs to the families of drugs called VEGF receptor and angiogenesis inhibitors. Also called Angiozyme.



Previous Definitions:romiplostim, ropivacaine, ropivacaine hydrochloride, rosiglitazone, rosiglitazone maleate
Next Definitions:RPR 109881A, RSR13, RSV, RTA 744, RU 486

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov